Publications searcher The science produced by our scientists is very important. In 2024, 1,501 papers were published in scientific journals with an average impact factor of over 7.13 points. Fulltext search Alphabetic A-Z Alphabetic Z-A Association of rhinitis with asthma prevalence and severity. PMID: 35430600 Journal: Scientific Reports Year: 2022 Reference: Sci Rep. 2022 Apr 16;12(1):6389. doi: 10.1038/s41598-022-10448-w. Impact factor: 4.38 Publication type: Paper in international publication Authors: Acevedo-Prado, Antonio, Seoane-Pillado, Teresa, Lopez-Silvarrey-Varela, Angel, Salgado, Francisco-Javier, Cruz, Maria-Jesus, Faraldo-Garcia, Ana, Nieto-Fontarigo, Juan-Jose, Pertega-Diaz, Sonia, Sanchez-Lastres, J, San-Jose-Gonzalez, Miguel-Angel et al. DOI: 10.1038/s41598-022-10448-w Association of rhinitis with asthma prevalence and severity. PMID: 35430600 Journal: Scientific Reports Year: 2022 Reference: Sci Rep. 2022 Apr 16;12(1):6389. doi: 10.1038/s41598-022-10448-w. Impact factor: Publication type: Paper in international publication Authors: Acevedo-Prado, Antonio; Bamonde-Rodriguez, Luis; Cruz, Maria-Jesus; Faraldo-Garcia, Ana; Garnelo-Suarez, Luciano; Gonzalez-Barcala, Francisco-Javier; Lopez-Silvarrey-Varela, Angel; Nieto-Fontarigo, Juan-Jose; Perez-Castro, Teresa; Pertega-Diaz, Sonia et al. DOI: 10.1038/s41598-022-10448-w Association of the Time to Immune Checkpoint Inhibitor (ICI) Initiation and Outcomes With Second Line ICI in Patients With Advanced Urothelial Carcinoma. PMID: 36155169 Journal: Clinical Genitourinary Cancer Year: 2022 Reference: Clin Genitourin Cancer. 2022 Dec;20(6):558-567. doi: 10.1016/j.clgc.2022.08.006. Epub 2022 Aug 19. Impact factor: Publication type: Paper in international publication Authors: Agarwal, Neeraj; Alva, Ajjai; Bamias, Aristotelis; Barata, Pedro; Bilen, Mehmet A; Buznego, Lucia Alonso; Carril-Ajuria, Lucia; Castellano, Daniel; Cortellini, Alessio; Dawsey, Scott et al. DOI: 10.1016/j.clgc.2022.08.006 Association of Tumor Mutational Burden with Efficacy of Pembrolizumab{plus minus}Chemotherapy as First-Line Therapy for Gastric Cancer in the Phase III KEYNOTE-062 Study. PMID: 35657979 Journal: CLINICAL CANCER RESEARCH Year: 2022 Reference: Clin Cancer Res. 2022 Jun 3. pii: 699374. doi: 10.1158/1078-0432.CCR-22-0121. Impact factor: 12.531 Publication type: Paper in international publication Authors: Cao, Z Alexander, Aurora-Garg, Deepti, Kobie, Julie, Cristescu, Razvan, Bhagia, Pooja, Shah, Sukrut, Tabernero, Josep, Shitara, Kohei, Wyrwicz, Lucjan, Wainberg, Zev A et al. DOI: 10.1158/1078-0432.CCR-22-0121 Association of Tumor Mutational Burden with Efficacy of Pembrolizumab{plus minus}Chemotherapy as First-Line Therapy for Gastric Cancer in the Phase III KEYNOTE-062 Study. PMID: 35657979 Journal: CLINICAL CANCER RESEARCH Year: 2022 Reference: Clin Cancer Res. 2022 Aug 15;28(16):3489-3498. doi: 10.1158/1078-0432.CCR-22-0121. Impact factor: Publication type: Paper in international publication Authors: Aurora-Garg, Deepti; Bang, Yung-Jue; Bhagia, Pooja; Cao, Z Alexander; Castro, Hugo R; Chao, Joseph; Chung, Hyun Cheol; Cristescu, Razvan; Fuchs, Charles S; Garrido, Marcelo et al. DOI: 10.1158/1078-0432.CCR-22-0121 Astrocytic outer retinal layer thinning is not a feature in AQP4-IgG seropositive neuromyelitis optica spectrum disorders. PMID: 34711650 Journal: JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY Year: 2022 Reference: J Neurol Neurosurg Psychiatry. 2022 Feb;93(2):188-195. doi: 10.1136/jnnp-2021-327412. Epub 2021 Oct 28. Impact factor: 10.283 Publication type: Paper in international publication Authors: Radaelli, Marta, Lu, Angelo, Zimmermann, Hanna G, Specovius, Svenja, Motamedi, Seyedamirhosein, Chien, Claudia, Bereuter, Charlotte, Lana-Peixoto, Marco A, Fontenelle, Mariana Andrade, Ashtari, Fereshteh et al. DOI: 10.1136/jnnp-2021-327412 Astrocytic outer retinal layer thinning is not a feature in AQP4-IgG seropositive neuromyelitis optica spectrum disorders. PMID: 34711650 Journal: JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY Year: 2022 Reference: J Neurol Neurosurg Psychiatry. 2022 Feb;93(2):188-195. doi: 10.1136/jnnp-2021-327412. Epub 2021 Oct 28. Impact factor: Publication type: Paper in international publication Authors: Aktas, Orhan; Albrecht, Philipp; Altintas, Ayse; Asgari, Nasrin; Ashtari, Fereshteh; Bereuter, Charlotte; Bichuetti, Denis Bernardi; Brandt, Alexander U; Chien, Claudia; Cobo-Calvo, Alvaro et al. DOI: 10.1136/jnnp-2021-327412 Asymptomatic carriers of mutations in succinate dehydrogenase (SDHx) genes. In search of consensus for follow-up. PMID: 35353683 Journal: Endocrinologia Diabetes y Nutricion Year: 2022 Reference: Endocrinol Diabetes Nutr (Engl Ed). 2022 Mar;69(3):157-159. doi: 10.1016/j.endien.2022.01.008. Epub 2022 Mar 4. Impact factor: 1.417 Publication type: Editorial in national publication Authors: Navarro Gonzalez, Elena, Romero Lluch, Ana, Casteras Roman, Anna et al. DOI: 10.1016/j.endien.2022.01.008 Asymptomatic carriers of mutations in succinate dehydrogenase (SDHx) genes. In search of consensus for follow-up. PMID: 35353683 Journal: Endocrinologia Diabetes y Nutricion Year: 2022 Reference: Endocrinol Diabetes Nutr (Engl Ed). 2022 Mar;69(3):157-159. doi: 10.1016/j.endien.2022.01.008. Epub 2022 Mar 4. Impact factor: Publication type: Editorial in national publication Authors: Casteras Roman, Anna; Navarro Gonzalez, Elena; Romero Lluch, Ana et al. DOI: 10.1016/j.endien.2022.01.008 Atezolizumab versus chemotherapy in advanced or metastatic NSCLC with high blood-based tumor mutational burden: primary analysis of BFAST cohort C randomized phase 3 trial. PMID: 35995953 Journal: NATURE MEDICINE Year: 2022 Reference: Nat Med. 2022 Sep;28(9):1831-1839. doi: 10.1038/s41591-022-01933-w. Epub 2022 Aug 22. Impact factor: Publication type: Paper in international publication Authors: Andric, Zoran; Barrios, Carlos H; Cheema, Parneet; Cobo, Manuel; Danchaivijitr, Pongwut; Dansin, Eric; Dziadziuszko, Rafal; Fabrizio, David A; Felip, Enriqueta; Gadgeel, Shirish M et al. DOI: 10.1038/s41591-022-01933-w ATOMICC trial: a randomized, open-label, phase II trial of anti-PD1, dostarlimab, as maintenance therapy for patients with high-risk locally advanced cervical cancer after chemoradiation. PMID: 35444013 Journal: INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER Year: 2022 Reference: Int J Gynecol Cancer. 2022 Apr 20. pii: ijgc-2022-003370. doi: 10.1136/ijgc-2022-003370. Impact factor: 3.437 Publication type: Paper in international publication Authors: Garcia-Duran, Carmen, Grau, Francisco, Villacampa, Guillermo, Oaknin, Ana et al. DOI: 10.1136/ijgc-2022-003370 ATOMICC trial: a randomized, open-label, phase II trial of anti-PD1, dostarlimab, as maintenance therapy for patients with high-risk locally advanced cervical cancer after chemoradiation. PMID: 35444013 Journal: INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER Year: 2022 Reference: Int J Gynecol Cancer. 2022 Sep 6;32(9):1196-1200. doi: 10.1136/ijgc-2022-003370. Impact factor: Publication type: Paper in international publication Authors: Garcia-Duran, Carmen; Grau, Francisco; Oaknin, Ana; Villacampa, Guillermo et al. DOI: 10.1136/ijgc-2022-003370 Atrial Fibrillation and Dementia: A Report From the AF-SCREEN International Collaboration. PMID: 35100023 Journal: CIRCULATION Year: 2022 Reference: Circulation. 2022 Feb;145(5):392-409. doi: 10.1161/CIRCULATIONAHA.121.055018. Epub 2022 Jan 31. Impact factor: 29.69 Publication type: Paper in international publication Authors: Connolly, Stuart, Dagres, Nikolaos, Elkind, Mitchell S V, Engdahl, Johan, Field, Thalia S, Gersh, Bernard J, Glotzer, Taya V, Hankey, Graeme J, Harbison, Joseph A, Georg Haeusler, Karl et al. DOI: 10.1161/CIRCULATIONAHA.121.055018 Atrial Fibrillation and Dementia: A Report From the AF-SCREEN International Collaboration. PMID: 35100023 Journal: CIRCULATION Year: 2022 Reference: Circulation. 2022 Feb;145(5):392-409. doi: 10.1161/CIRCULATIONAHA.121.055018. Epub 2022 Jan 31. Impact factor: Publication type: Paper in international publication Authors: Berge, Trygve; Boriani, Giuseppe; Brandes, Axel; Calkins, Hugh; Camm, A John; Collins, Ronan; Conen, David; Connolly, Stuart; Dagres, Nikolaos; Elkind, Mitchell S V et al. DOI: 10.1161/CIRCULATIONAHA.121.055018 Attention deficit hyperactivity disorder symptoms and cannabis use after one year among students of the i-Share cohort. PMID: 35348052 Journal: EUROPEAN PSYCHIATRY Year: 2022 Reference: Eur Psychiatry. 2022 Mar 29:1-18. doi: 10.1192/j.eurpsy.2022.14. Impact factor: 5.361 Publication type: Paper in international publication Authors: Jean, Francois Arnaud Matthieu, Arsandaux, Julie, Montagni, Ilaria, Collet, Ophelie, Fatseas, Melina, Auriacombe, Marc, Ramos-Quiroga, Josep Antoni, Cote, Sylvana M, Tzourio, Christophe, Galera, Cedric et al. DOI: 10.1192/j.eurpsy.2022.14 Attention deficit hyperactivity disorder symptoms and cannabis use after one year among students of the i-Share cohort. PMID: 35348052 Journal: EUROPEAN PSYCHIATRY Year: 2022 Reference: Eur Psychiatry. 2022 Mar 29;65(1):1-18. doi: 10.1192/j.eurpsy.2022.14. Impact factor: Publication type: Paper in international publication Authors: Arsandaux, Julie; Auriacombe, Marc; Collet, Ophelie; Cote, Sylvana M; Fatseas, Melina; Galera, Cedric; Jean, Francois Arnaud Matthieu; Montagni, Ilaria; Ramos-Quiroga, Josep Antoni; Tzourio, Christophe et al. DOI: 10.1192/j.eurpsy.2022.14 Atypical Sympathetic Ophthalmia Presenting with Ocular Pain Associated with Posterior Scleral Involvement. PMID: 33734929 Journal: OCULAR IMMUNOLOGY AND INFLAMMATION Year: 2022 Reference: Ocul Immunol Inflamm. 2022 Aug;30(6):1460-1463. doi: 10.1080/09273948.2021.1891261. Epub 2021 Mar 18. Impact factor: Publication type: Paper in international publication Authors: Aragon, David; Banderas, Sandra; Garrell, Xavier; Iribarren, Maria Del Carmen; Segura, Antonio; Trejo, Fernando et al. DOI: 10.1080/09273948.2021.1891261 Author Correction: Genome-wide association analyses identify new Brugada syndrome risk loci and highlight a new mechanism of sodium channel regulation in disease susceptibility. PMID: 35474365 Journal: NATURE GENETICS Year: 2022 Reference: Nat Genet. 2022 May;54(5):735. doi: 10.1038/s41588-022-01079-y. Impact factor: 38.33 Publication type: Letter or abstract Authors: Van Dooren, Sonia, Potet, Franck, Offerhaus, Joost A, Walsh, Roddy, Choi, Seung Hoan, Verkerk, Arie O, Mizusawa, Yuka, Anys, Soraya, Minois, Damien, Arnaud, Marine et al. DOI: 10.1038/s41588-022-01079-y Author Correction: Genome-wide association analyses identify new Brugada syndrome risk loci and highlight a new mechanism of sodium channel regulation in disease susceptibility. PMID: 35474365 Journal: NATURE GENETICS Year: 2022 Reference: Nat Genet. 2022 May;54(5):735. doi: 10.1038/s41588-022-01079-y. Impact factor: Publication type: Letter or abstract Authors: Anselme, Frederic; Antzelevitch, Charles; Anys, Soraya; Arbelo, Elena; Arnaout, Alain Al; Arnaud, Marine; Babuty, Dominique; Barajas-Martinez, Hector; Barc, Julien; Baron, Estelle et al. DOI: 10.1038/s41588-022-01079-y Author Correction: High p16 expression and heterozygous RB1 loss are biomarkers for CDK4/6 inhibitor resistance in ER(+) breast cancer. PMID: 36376284 Journal: Nature Communications Year: 2022 Reference: Nat Commun. 2022 Nov 14;13(1):6928. doi: 10.1038/s41467-022-34580-3. Impact factor: Publication type: Letter or abstract Authors: Arnedos, Monica; Arribas, Joaquin; Azaro, Analia; Bellet, Meritxell; Braso-Maristany, Fara; Bruna, Alejandra; Caldas, Carlos; Capelan, Marta; Clarke, Robert B; Dienstmann, Rodrigo et al. DOI: 10.1038/s41467-022-34580-3 Author Correction: Impact of interstitial lung disease on the survival of systemic sclerosis with pulmonary arterial hypertension. PMID: 35902683 Journal: Scientific Reports Year: 2022 Reference: Sci Rep. 2022 Jul 28;12(1):12947. doi: 10.1038/s41598-022-17525-0. Impact factor: Publication type: Letter or abstract Authors: Argibay, Ana; Argibay, Ana; Arjona, Josefa Jimenez; Baldomero, Idaira Famara Hernandez; Ballve, Adela Marin; Barbera, Joan Albert; Barbera, Joan Albert; Blanco, Isabel; Blanco, Isabel; Candelera, Remedios Otero et al. DOI: 10.1038/s41598-022-17525-0 Author Correction: The Molecular Tumor Board Portal supports clinical decisions and automated reporting for precision oncology. PMID: 35449310 Journal: Nature cancer Year: 2022 Reference: Nat Cancer. 2022 May;3(5):649. doi: 10.1038/s43018-022-00378-x. Impact factor: 0 Publication type: Letter or abstract Authors: Ernberg, Ingemar, Frohling, Stefan, Garralda, Elena, Karlsson, Claes, Tabernero, Josep, Voest, Emile, Rodon, Jordi, Lehtio, Janne, Anand, Shubha, Baars, Danny et al. DOI: 10.1038/s43018-022-00378-x Author Correction: The Molecular Tumor Board Portal supports clinical decisions and automated reporting for precision oncology. PMID: 35449310 Journal: Nature Cancer Year: 2022 Reference: Nat Cancer. 2022 May;3(5):649. doi: 10.1038/s43018-022-00378-x. Impact factor: Publication type: Letter or abstract Authors: Anand, Shubha; Apolone, Giovanni; Baars, Danny; Baird, Richard; Baird, Richard D; Bajalica-Lagercrantz, Svetlana; Balmana, Judith; Bergh, Jonas; Bierkens, Mariska; Blomqvist, Lennart et al. DOI: 10.1038/s43018-022-00378-x Author response to: European Hernia Society guidelines on management of rectus diastasis. PMID: 34791061 Journal: British Journal of Surgery Year: 2022 Reference: Br J Surg. 2022 Feb 1;109(2):e42. doi: 10.1093/bjs/znab393. Impact factor: Publication type: Paper in international publication Authors: Berrevoet, Frederik; Cuccurullo, Diego; Henriksen, Nadia; Hernandez-Granados, Pilar; Lopez-Cano, Manuel; Montgomery, Agneta; Nienhuijs, Simon; Ross, David et al. DOI: 10.1093/bjs/znab393 Pagination First page « First Previous page ‹ Previous … Page 144 Page 145 Page 146 Page 147 Current page 148 Page 149 Page 150 Page 151 Page 152 … Next page Next › Last page Last »
